CPhI Biosimilars India 2009 Conference: Mr. Mahesh's presentations on " Evaluating The Latest Biological Clinical Trial Methodologies To Achieve Speed to market, And Cost effective Development"
HYDERABAD: UBM International Media is a division of United Business Media Ltd., London. It is responsible for the organisation of the world's leading CPhI, P-MEC, ICSE, BioPh, series of pharmaceutical and food ingredient trade shows. "Biosimilars India 2009" - Taking place at CPhI India 2009 at Bombay Exhibition Centre, Mumbai on 1 - 2 December, 2009.
CPhI Biosimilars India 2009 consists of 3 half-day conference modules, each designed to provide solutions to the strategic issues faced by the Indian biosimilars market. Based on an in-depth research, each module provides 3.5 hours of business - critical information delivered by a hand-selected panel of expert speakers. Mr. Mahesh Malneedi, Managing Director, MakroCare was one among the speakers at Module 3 - Biosimilars Cost Effective Production - on Wednesday 2 December, 2009.
He presented papers on " Evaluating The Latest Biological Clinical Trial Methodologies to Achieve Speed to market, and Cost Effective Development".To download the presentations from the Biosimilars India conference,
The Indian biosimilars market is on the verge of rapid expansion. With patents due to expire and millions of dollars being invested by the Indian government, all the key players in the Indian pharmaceutical market are looking to maximise the potential of biologics, whilst reducing cost and risk. As companies race to get their strategy together, this timely conference provides all the information you need to maximise the opportunities and develop your strategy for success.
Mr. Mahesh's presentation received immense appreciation from the august gathering of more than 500 delegates from national and international Life Science industry.